RSS Feeds

Get PharmaAsia headlines daily as soon as they publish.

Receive PharmaAsia's latest news, breaking news, issue articles, blog postings and columns as soon as we publish them. Depending on your RSS reader, you can drag the orange "Subscribe" button into your news aggregator program and it will subscribe you to our feeds. Alternatively, right-click and choose "Copy shortcut," then paste the address into your RSS program.

rssbut PharmaAsia Latest Updates

rssbut Drug Discovery

rssbut Drug Development

rssbut Drug Manufacturing

rssbut Drug Delivery

rssbut Clinical Trials

rssbut Regulatory and Legal

rssbut Alliances and Mergers

rssbut QA/QC and Compliance

rssbut Pharmaceutical Processing and Packaging


What's this RSS thing? How do I use it?

RSS (really simple syndication) allows Web sites to make their most recent content available to you automatically. A program called an RSS reader, or "aggregator," helps you to organize and view the various RSS feeds to which you choose to subscribe. Most feeds (OnScreenAsia's included) contain a headline, an abstract, and a link to each new item. The power of RSS lies in its ability to bring all of the news and content that interests you into one place. Rather than visiting 10 Web sites, you fire up your reader and quickly see what all of them have published. Then you click through to the articles that you want to read.

Get a reader: To take advantage of RSS feeds, you need an RSS reader/aggregator. Generally, these tools come in two forms: A program that you install on your computer (sometimes integrated into your email program), or a Web-based service. Both Yahoo!, with its My Yahoo! offering, and Google, with Google Reader, make it pretty easy to get started, and RSS is now integrated into the latest versions of both Internet Explorer and Firefox.

What RSS is not

PharmaAsia's RSS headline service is not intended as a substitute for licensing the complete content of our articles. Please contact Raymond Foo at raymond.foo@rbi-asia.com if you'd like to use our article content.